amrinone has been researched along with alprostadil in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Banerjee, A; Fullerton, DA; Hahn, AR; Harken, AH | 1 |
| Kashimoto, S; Kumazawa, T; Matsukawa, T; Nonaka, A | 1 |
| Harii, K; Ichioka, S; Kamiya, A; Nakatsuka, T; Sato, Y; Shibata, M | 1 |
| Heintz, B; Kirsten, D; Kirsten, R; Nelson, K | 1 |
| Chang, K; Hanaoka, K; Hayashida, M; Makuuchi, M; Orii, R; Sugawara, Y; Takayama, T; Yamada, Y | 1 |
| Ikeda, T; Kazama, T; Kikura, M; Sato, S | 1 |
| Harii, K; Ichioka, S; Nakatsuka, T; Ohura, N; Sato, Y | 1 |
1 review(s) available for amrinone and alprostadil
| Article | Year |
|---|---|
Clinical pharmacokinetics of vasodilators. Part II.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Alprostadil; Amrinone; Carbazoles; Carvedilol; Enoximone; Female; Humans; Iloprost; Imidazoles; Indoramin; Isosorbide Dinitrate; Labetalol; Milrinone; Molsidomine; Nitroglycerin; Nitroprusside; Oxyfedrine; Pentaerythritol Tetranitrate; Phosphodiesterase Inhibitors; Piperazines; Prazosin; Pregnancy; Propanolamines; Pyridones; Theophylline; Trapidil; Vasodilator Agents | 1998 |
3 trial(s) available for amrinone and alprostadil
| Article | Year |
|---|---|
[Effects of amrinon and prostaglandin E1 on intraoperative central and peripheral temperatures during peripheral arterial surgery].
Topics: Aged; Alprostadil; Amrinone; Anesthesia, Epidural; Anesthesia, General; Arterial Occlusive Diseases; Body Temperature Regulation; Female; Humans; Intraoperative Period; Male; Middle Aged; Vasodilator Agents | 1996 |
Effects of amrinone on ischaemia-reperfusion injury in cirrhotic patients undergoing hepatectomy: a comparative study with prostaglandin E1.
Topics: Aged; Alprostadil; Amrinone; Analysis of Variance; Female; Hepatectomy; Humans; Indocyanine Green; Lactic Acid; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Reperfusion Injury | 2000 |
Clinical use of amrinone (a selective phosphodiesterase III inhibitor) in reconstructive surgery.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Alprostadil; Amrinone; Blood Flow Velocity; Cyclic Nucleotide Phosphodiesterases, Type 3; Female; Humans; Intraoperative Complications; Laser-Doppler Flowmetry; Lidocaine; Male; Middle Aged; Phosphodiesterase Inhibitors; Plastic Surgery Procedures; Surgical Flaps; Vasoconstriction; Vasodilator Agents | 2001 |
8 other study(ies) available for amrinone and alprostadil
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Pulmonary vascular smooth muscle relaxation by cGMP- versus cAMP-mediated mechanisms.
Topics: Alprostadil; Amrinone; Analysis of Variance; Animals; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Guanylate Cyclase; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroglycerin; Nitroprusside; Phosphodiesterase Inhibitors; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Prostaglandin E; Vasodilation; Vasodilator Agents | 1994 |
Amrinone, a selective phosphodiesterase III inhibitor, improves microcirculation and flap survival: a comparative study with prostaglandin E1.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Alprostadil; Amrinone; Animals; Blood Flow Velocity; Blood Pressure; Cyclic Nucleotide Phosphodiesterases, Type 3; Ischemia; Male; Microcirculation; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Surgical Flaps; Vasodilation | 1998 |
Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood.
Topics: Adenosine Diphosphate; Adult; Alprostadil; Amrinone; Cardiotonic Agents; Collagen; Cyclic AMP; Dose-Response Relationship, Drug; Electrochemistry; Humans; Kinetics; Male; Middle Aged; Milrinone; Platelet Aggregation; Platelet Aggregation Inhibitors; Vasodilator Agents | 2000 |